You may have heard it's coming, and now it's here: monoclonal antibody therapy to assist in the treatment of lymphoma in your canine veterinary patients.
Cancer. One word guaranteed to sober any veterinary exam room. But a new weapon of mass destruction just aimed its sights on one of the most common forms of canine cancer, lymphoma, as veterinary oncologist Dr. Sue Ettinger told us at CVC Virginia Beach in May. Used in conjunction with chemotherapy, monoclonal antibody therapy (e.g. Blontress-Aratana) flags cancer cells so the dog's immune system can attack them. Hear more:
Urinalysis offers a noninasive, rapid screening for canine cancer detection
February 9th 2024This is the first rapid test using urine developed by the Virginia Tech College of Engineering, College of Agriculture and Life Sciences, and the Virginia-Maryland College of Veterinary Medicine
Read More